Onc.AI presented results at the Society for Immunotherapy of Cancer (SITC), showcasing a multi-institutional study demonstrating that Serial CTRS improved the prediction of overall survival for ...

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).

Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.

We recently published a list of 12 AI News and Ratings Investors are Keeping Their Eye On. In this article, we are going to ...